Výsledky vyhledávání

Mutational analyses ofBRCA1 andBRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer

Autor: Revital Bruchim Bar Sade, Limor Green, Samario Haitchick, Eitan Friedman, Peter J. Oefner, Anna Kruglikova, Efrat Dagan, Robert M.W. Hofstra, Rizel S, Ruth Gershoni Baruch, Inge M. Mulder, Ronit Shiri-Sverdlov, Ziad Abdeen, Boleslaw Goldman, Moshe Z. Papa, Teresa Wagner

Publikováno v: Human Mutation. 16:491-501

In Ashkenazi (East European) Jews, three predominant mutations in BRCA1 (185delAG and 5382insC) and BRCA2 (6174-delT) account for the majority of germline mutations in high risk breast and/or ovarian cancer families. Among non-Ashkenazi Jews, the 185

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ac53abe60e951e9b3e7f301f7f30d6f7
https://doi.org/10.1002/1098-1004(200012)16:6<491::aid-humu6>3.0.co

Zobrazit plný text záznamu

Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer

Autor: Ronit Shiri-Sverdlov, Peter Oefner, Limor Green, Ruth Gershoni Baruch, Teresa Wagner, Anna Kruglikova, Samario Haitchick, Robert M.W. Hofstra, Moshe Z. Papa, Inge Mulder, Shulamit Rizel, Revital Bruchim Bar Sade, Efrat Dagan, Ziad Abdeen, Boleslaw Goldman, Eitan Friedman

Publikováno v: Human mutation. 16(6)

In Ashkenazi (East European) Jews, three predominant mutations in BRCA1 (185delAG and 5382insC) and BRCA2 (6174delT) account for the majority of germline mutations in high-risk breast and/or ovarian cancer families. Among non-Ashkenazi Jews, the 185d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50217e7a2af7784ed2664ce53607e3fb
https://pubmed.ncbi.nlm.nih.gov/11102978

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání